Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial Keith B Allen, MD, Robert D Dowling, MD, William W.

Slides:

Advertisements

Similar presentations

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Advertisements

Photodynamic Laser Therapy for Lesions in the Airway

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Robert M. Kaplan, PhD, Qiankun Sun, PhD, Keith S

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

Outcomes of Reintervention on the Autograft After Ross Procedure

Joshua E. Rosen, BASc, Hari B

Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer Lars P. Riber, MD, PhD, Thomas D. Christensen,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Amr Mohammad Allama, MD The Annals of Thoracic Surgery

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations Giovanni Filardo, PhD, MPH, Paul.

The Impact of Specific Preoperative Organ Dysfunction in Patients Undergoing Aortic Valve Replacement Vinod H. Thourani, MD, Ritam Chowdhury, MD, Rebecca.

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Operative Results and Outcomes in Children With Shone's Anomaly

Anthony Lemaire, MD, William R

Total Arch Replacement With Stented Elephant Trunk Technique for Acute Type B Aortic Dissection Involving the Aortic Arch Hai-Peng Zhao, MD, Jun-Ming.

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Established Preoperative Risk Factors Do Not Predict Long-Term Survival in Isolated Coronary Artery Bypass Grafting Patients Giovanni Filardo, PhD, MPH,

Radial Artery Grafts in Women: Utilization and Results

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Sam Chitsaz, MD, Nicolas Jaussaud, MD, Edward Chau, MD, Kimberly S

Expanding Indications for Valve-Sparing Aortic Root Reconstruction: Early and Midterm Results Johanna Valo, BM, Janne J. Jokinen, MD, PhD, Markku Kaarne,

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Transmyocardial laser revascularization combined with coronary artery bypass grafting: A multicenter, blinded, prospective, randomized, controlled trial

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Induction Therapy With Antithymocyte Globulin Before Reperfusion

Michael Lanuti, MD, Pierre E

Sternal Closure With Tie Bands: A Word of Caution

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Editorial Board, January 2010

William M. Whited, MD, Paul Henley, BS, Erin M

Surgical Treatment of Aortic Prosthetic Valve Endocarditis: A 20-Year Single-Center Experience Sossio Perrotta, MD, Anders Jeppsson, MD, PhD, Victoria.

Listing Low-Weight or Ill Infants for Heart Transplantation: Is It Prudent? Raheel Rizwan, MD, Farhan Zafar, MD, Clifford Chin, MD, James Tweddell, MD,

Robert M. Kaplan, PhD, Qiankun Sun, PhD, Keith S

Attila Dubecz, MD, Thomas J. Watson, MD, Daniel P

Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Bullectomy for Symptomatic or Complicated Giant Lung Bullae

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

Completeness of Revascularization and Survival Among Octogenarians With Triple- Vessel Disease Siamak Mohammadi, MD, Dimitri Kalavrouziotis, MD, Francois.

Luis F. Tapias, MD, Douglas J. Mathisen, MD, Cameron D

Hybrid Debranching With Endovascular Repair for Thoracoabdominal Aneurysms: A Comparison With Open Repair Himanshu J. Patel, MD, Gilbert R. Upchurch,

The American Board of Thoracic Surgery: Update

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Early and Midterm Outcomes for Tricuspid Valve Surgery After Left-Sided Valve Surgery Choung Kyu Park, MD, Pyo Won Park, MD, Kiick Sung, MD, Young Tak.

Transmyocardial laser revascularization in the patient with unmanageable unstable angina Brack G Hattler, MD, PhD, Bartley P Griffith, MD, Marco A Zenati,

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

The Impact of New Technology on Cardiothoracic Surgical Practice

Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement Heinrich Koertke, MD,

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Presentation transcript:

Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial Keith B Allen, MD, Robert D Dowling, MD, William W Angell, MD, Deepak M Gangahar, MD, Tommy L Fudge, MD, Wayne Richenbacher, MD, Samuel L Selinger, MD, Michael R Petracek, MD, Douglas Murphy, MD The Annals of Thoracic Surgery Volume 77, Issue 4, Pages 1228-1234 (April 2004) DOI: 10.1016/j.athoracsur.2004.01.008

Fig 1 Mean Canadian Cardiovascular Society angina class in surviving patients after transmyocardial revascularization. The Annals of Thoracic Surgery 2004 77, 1228-1234DOI: (10.1016/j.athoracsur.2004.01.008)

Fig 2 Improvement in Canadian Cardiovascular Society angina class at 3 months, 1 year, and a mean of 5 years. *Comparison between transmyocardial revascularization (TMR) and medical therapy. (Crossover = patients randomized to medical therapy who met the criteria for treatment failure and underwent transmyocardial revascularization while unstable; Medical Therapy = patients randomized to medical therapy excluding crossovers; TMR = patients randomized to transmyocardial revascularization.) The Annals of Thoracic Surgery 2004 77, 1228-1234DOI: (10.1016/j.athoracsur.2004.01.008)

Fig 3 Kaplan-Meier intention-to-treat survival estimates. (MMM = continued maximal medical management; TMR = transmyocardial revascularization.) The Annals of Thoracic Surgery 2004 77, 1228-1234DOI: (10.1016/j.athoracsur.2004.01.008)

Fig 4 Cumulative hazard (CH) intention-to-treat analysis. (MMM = continued maximal medical management; TMR = transmyocardial revascularization.) The Annals of Thoracic Surgery 2004 77, 1228-1234DOI: (10.1016/j.athoracsur.2004.01.008)

Fig 5 Kaplan-Meier 5-year survival estimates. (Crossover = patients randomized to medical therapy who met the criteria for treatment failure and underwent transmyocardial revascularization while unstable; Medical Therapy = patients randomized to medical therapy excluding crossovers; TMR = patients randomized to transmyocardial revascularization.) The Annals of Thoracic Surgery 2004 77, 1228-1234DOI: (10.1016/j.athoracsur.2004.01.008)